Financial statements Upward Pharma W Likwidacji

Balance sheet of Upward Pharma W Likwidacji

Company age:
Age:
6 y. 4 m. 21 d.
Share capital:
Share capital:
100 000 PLN

Balance sheet data of UPWARD PHARMA W LIKWIDACJI

Year
2019
2020
2021
2022
2023
Total assets 387 226,94 226 034,00 209 182,14 25 690,55 16 809,89
A. Fixed assets 0,00 0,00 0,00 0,00 0,00
B. Current assets 387 226,94 226 034,00 209 182,14 25 690,55 16 809,89
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00
Total liabilities 387 226,94 226 034,00 209 182,14 25 690,55 16 809,89
A. Equity 93 880,73 -26 423,44 -35 817,86 -219 801,45 -229 363,11
B. Liabilities and provisions for liabilities 293 346,21 252 457,44 245 000,00 245 492,00 246 173,00
I. Long-term liabilities - - - - -
II. Short-term liabilities - - - - -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.